These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 8882950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.
    Pilarski LM, Mant MJ, Belch AR.
    Leuk Lymphoma; 1999 Jan; 32(3-4):199-210. PubMed ID: 10037018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N, Schuster-Kolbe J, Assmann I, Ackermann J, Strasser K, Hübl W, Drach J, Ludwig H.
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating monoclonal B lymphocytes in multiple myeloma.
    Chiu EK, Ganeshaguru K, Hoffbrand AV, Mehta AB.
    Br J Haematol; 1989 May; 72(1):28-31. PubMed ID: 2786732
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.
    Trepel M, Martens V, Doll C, Rahlff J, Gösch B, Loges S, Binder M.
    PLoS One; 2012 May; 7(2):e31998. PubMed ID: 22384124
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Thiago LS, Perez-Andres M, Balanzategui A, Sarasquete ME, Paiva B, Jara-Acevedo M, Barcena P, Sanchez ML, Almeida J, González M, San Miguel JF, Garcia-Sanz R, Orfao A.
    Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
    [Abstract] [Full Text] [Related]

  • 16. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM, Seeberger K, Coupland RW, Eshpeter A, Keats JJ, Taylor BJ, Belch AR.
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [Abstract] [Full Text] [Related]

  • 17. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF.
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [Abstract] [Full Text] [Related]

  • 18. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
    Jensen GS, Mant MJ, Belch AJ, Berenson JR, Ruether BA, Pilarski LM.
    Blood; 1991 Aug 01; 78(3):711-9. PubMed ID: 1830500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.